Trajenta 5 mg is a pharmaceutical product that falls under the category of antidiabetic medications. It contains the active ingredient linagliptin, which is commonly prescribed to manage blood sugar levels in individuals with type 2 diabetes.
Ingredients
Each tablet of Trajenta 5 mg contains linagliptin as the active ingredient. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate blood glucose levels by increasing the release of insulin and reducing the production of glucagon, a hormone that raises blood sugar levels.
Product
Trajenta 5 mg is an oral medication used to control blood sugar levels in patients with type 2 diabetes. It is part of a class of drugs known as DPP-4 inhibitors, which work by enhancing the body’s natural mechanisms for blood sugar regulation. It is often prescribed as part of a comprehensive diabetes management plan.
Usage
Patients should take Trajenta 5 mg as directed by their healthcare provider. The typical dosage is one tablet (5 mg) once daily. It is important to follow the prescribed regimen consistently. The medication can be taken with or without food. Patients should not adjust the dosage without consulting their healthcare provider.
Manufacturer
Trajenta 5 mg is manufactured by Boehringer Ingelheim, a well-known pharmaceutical company recognized for producing high-quality medications. Boehringer Ingelheim is committed to ensuring that its products meet rigorous quality standards, especially in the field of diabetes management.
In summary, Trajenta 5 mg is an oral medication containing linagliptin, a DPP-4 inhibitor, used to help manage blood sugar levels in individuals with type 2 diabetes. Patients should adhere to their healthcare provider’s instructions for safe and effective use, and they should consult their healthcare provider for personalized guidance on using Trajenta 5 mg to control their specific diabetes-related concerns.
Reviews
There are no reviews yet.